OTTAWA, ON / ACCESSWIRE / September 17, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP.TO) (OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, is pleased to announce that Ms. Dale Weil and Dr. Brent Norton have been appointed to the Company's Board of Directors and Dr. Graham Wood, Ph.D. has been appointed as Chief Operating Officer. Steeve Neron, who served as COO...
Read more
Grant enables the development of new detection technologies for DJ-1 in biofluids to create a new biomarker for the potential early diagnosis and tracking of the progression of Parkinson's disease PALO ALTO, CA / ACCESSWIRE / September 16, 2020 / Cantabio Pharmaceuticals, Inc. ("Cantabio" or the "Company"), a preclinical stage pharmaceutical company developing disease modifying therapeutics for Alzheimer's (AD),...
Read more
Havn Life is now cross-listed and trades on both the CSE & FSE VANCOUVER, BC / ACCESSWIRE / September 16, 2020 / Havn Life Sciences Inc. (CSE:HAVN)(FSE:5NP) (the "Company" or "Havn Life"), a biotechnology company focused on unlocking human potential using evidence-informed research, and developing standardized psychoactive compounds derived from plants and fungi, is pleased to announce that it has been accepted to...
Read more
VANCOUVER, BC / ACCESSWIRE / September 14, 2020 / Experion Holdings Ltd. (the "Company" or "Experion") (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) is pleased to announce that it has completed its first shipment to fulfill an initial purchase order from the Ontario Cannabis Store ("OCS"). This first purchase order consists of Citizen Stash's top strains including MAC1, Sunset Sherbert, Sage N'Sour and...
Read more
JUPITER, FL / ACCESSWIRE / September 14, 2020 / Dyadic International, Inc. ("Dyadic", or the "Company") (NASDAQ:DYAI) a global biotechnology company focused on further improving, applying and deploying its proprietary C1 gene expression platform to accelerate development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales, today announced that the Company's management will be attending...
Read more
CHEYENNE, WY / ACCESSWIRE / September 14, 2020 / Yulong Eco-Materials Limited (OTC PINK:YECO) today announced that it will focus its energies into building an incubator laboratory in Nashville,TN for the development of cell and extracellular vesicle (EV) based therapeutics. Dr. Jason Sanders recently relocated to Nashville and the Company is now negotiating lab space near the Vanderbilt University area. EV Biologics will develop a new...
Read more
High yields in bacterial fermentation systems support ability of DARPin® manufacturing to rapidly scale for global supply First and only, tri-specific antiviral demonstrating potential best-in-class potency in vivo First-in-human clinical trial initiation planned for November 2020 ZURICH-SCHLIEREN / ACCESSWIRE / September 14, 2020 / Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company that is developing a new...
Read more
VANCOUVER, BC / ACCESSWIRE / September 11, 2020 / Experion Holdings Ltd. (the "Company" or "Experion") (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) announced today that its Chief Financial Officer Kamini Hitkari has advised the Company of her decision to resign from the Company to pursue another opportunity. Mr. Sean McNeil, Chairman of the Board of Experion, will act in the capacity of Interim CFO effective immediately. The...
Read more
AUSTIN, TX / ACCESSWIRE / September 11, 2020 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that it will present at the HC Wainwright & Co. Global Investment Conference on Tuesday, September 15 at 3:00 PM Eastern Time. Todd Newton, CEO, and Stefanie Cavanaugh, CFO, will be presenting and available for one-on-one...
Read more
SANDUSKY, OH / ACCESSWIRE / September 11, 2020 / Rising Biosciences, Inc. (OTC PINK:RBII) CEO Arthur Hall noted the resumption of trading of RBII stock and announced the Environmental Protection Agency (EPA) has issued Establishment Number 96322-OH-3 for the company's new 10,000 square foot bottling plant and corporate headquarters in Sandusky, OH. "We will begin bottling in our new plant by October 1st, starting with our new...
Read more
OTTAWA, ON / ACCESSWIRE / September 11, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP) (OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, is pleased to announce the appointment of Jean-Francois Boily, CPA, CA, as Chief Financial Officer and member of the Company's executive team. He will join the Company on September 14th bringing vast experience in publicly traded...
Read more
ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / September 11, 2020 / Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company that is developing a new class of custom-built proteins known as DARPin® therapeutics, today announced that Patrick Amstutz, chief executive officer, will be presenting at the HC Wainwright 22nd Annual Global Investments Conference taking place September 14-16, 2020, as well as participating in a fireside chat...
Read moreAcquisition Launches NovAccess Shift, Focusing on Diagnostics and Therapeutics in Cancer CLEVELAND, OH / ACCESSWIRE / September 9, 2020 / NovAccess Global, Inc. (OTCPINK:XSNX), today announced that it has acquired 100% ownership of Pasadena-based StemVax Therapeutics from Innovest Global (OTCPINK:IVST). StemVax is a translational biotechnology company developing novel immunotherapies for brain tumor patients, featuring recently approved...
Read more
VANCOUVER, BC / ACCESSWIRE / SEPTEMBER 9 2020 / Experion Holdings Ltd. (the "Company" or "Experion") (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) announced today that CEO, Mr. Jarrett Malnarich will present live at VirtualInvestorConferences.com on September 10 at 4:00 PM EDT / 1:00 PM PDT. Experion invites shareholders, investors, advisors and analyst to attend this real-time, interactive presentation. This will be a live,...
Read more
Live video webcast with CEO, Jeffrey Eisenberg, on Wednesday, September 16th at 12:00 PM EDT FRAMINGHAM, MA / ACCESSWIRE / September 9, 2020 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing XCART™, a personalized CAR T platform technology engineered to target patient- and tumor-specific neoantigens, announced today that Jeffrey Eisenberg, Chief...
Read more
CHEYENNE, WY / ACCESSWIRE / September 9, 2020 / Yulong Eco-Materials Limited (OTC PINK:YECO) today announced that it intends to build an incubator laboratory for development of cell and extracellular vesicle (EV) based therapeutics. Our state-of-the-art molecular and cellular biology lab will be equipped for the development of a series of young new cells (naïve) and bioengineered cell lines including mesenchymal stem cells (MSCs) and...
Read more
DURHAM, NC / ACCESSWIRE / September 9, 2020 / Heat Biologics, Inc. ("Heat") (NASDAQ:HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, including multiple oncology product candidates and a novel COVID-19 vaccine, today announced that Jeff Wolf, CEO of Heat Biologics, will participate on a virtual panel, entitled, "New Approaches to COVID-19: Hidden...
Read more
SteriLumen Will Become Distributor in the U.S and the Greater Middle East to the Hospitality and Hotel Industry MOUNT VERNON, NY / ACCESSWIRE / September 8, 2020 / Applied UV, Inc. (NASDAQCM:AUVI) ("Applied UV" or the "Company"), an infection prevention technology company that applies the power of narrow-range ultra violet light ("UVC") utilizing its patented devices to destroy pathogens safely, thoroughly, and...
Read more
VANCOUVER, BC / ACCESSWIRE / September 4, 2020 / Havn Life Sciences Inc. (CSE:HAVN) (the "Company" or "Havn Life"), is pleased to announce that it has successfully completed its acquisition of HAVN Research Inc. ("HAVN Research"), acquiring 100% of the outstanding shares of HAVN Research (the "Acquisition Transaction"). HAVN Research is a biotechnology company engaged in the business of the research and...
Read more
BURBANK, CA / ACCESSWIRE / September 4, 2020 / Quanta, Inc. (OTC PINK:QNTA), an applied sciences company based on a quantum biology platform that significantly boosts the potency and efficiency of any plant-based matter, today announced another virtual "Town Hall" style investor event, which will be broadcast live over the internet on September 10, 2020 at 1:30 PM ET / 10:30 AM PT. Eric Rice, the company's Chief Executive...
Read more
